Calliditas Therapeutics AB
(NASDAQ GS: CALT)
Rigrodsky Law, P.A. is investigating Calliditas Therapeutics AB (“Calliditas”) regarding possible breaches of fiduciary duties and other violations of law related to Calliditas’ agreement to be acquired by Asahi Kasei Corporation. Under the terms of the agreement, Calliditas shareholders will receive SEK 416 in cash per American Depositary share.